# Legacy Pharmaceutical Packaging LLC, Earth City, MO – FDA Inspections Source: https://www.keypedia.com/companies/legacy-pharmaceutical-packaging-llc/c20cc0b4-a180-4bd8-be9b-9b4c62b26e8f > Inspection records and compliance data for Legacy Pharmaceutical Packaging LLC in Earth City, Missouri. 15 FDA inspections on record (2 OAI), 4 Form 483s, 1 warning letter, last inspected February 29, 2024. --- ## Details - Name: Legacy Pharmaceutical Packaging LLC - FEI Number: 3004453700 - Business Operations: REPACK - Address Line 1: 13333 Lakefront Dr - City: Earth City - State: Missouri - Zip Code: 63045 - Country Name: United States - Address: 13333 Lakefront Dr, Earth City, Missouri 63045, United States - Country: United States ## Related Documents - FDA Inspection 1229505 - Legacy Pharmaceutical Packaging LLC - 2024-02-29 — classification: Voluntary Action Indicated (VAI), source: FDA, date: February 29, 2024 - [483 - Legacy Pharmaceutical Packaging LLC - 2023-06-30](https://www.keypedia.com/records/483/legacy-pharmaceutical-packaging-llc/503cd539-6ac2-4cdf-96ef-ee2035fa6c8e) — source: FDA, date: June 30, 2023 - [FDA Inspection 1210234 - Legacy Pharmaceutical Packaging LLC - 2023-06-30](https://www.keypedia.com/records/fda_inspections/legacy-pharmaceutical-packaging-llc/beb7b7e6-17d9-4af2-9e3b-17aa2210d920) — classification: Official Action Indicated (OAI), source: FDA, date: June 30, 2023 - [483 - Legacy Pharmaceutical Packaging LLC - 2023-06-20](https://www.keypedia.com/records/483/legacy-pharmaceutical-packaging-llc/1e6d340f-d04a-41c7-b635-6e03d603e170) — source: FDA, date: June 20, 2023 - [FDA Inspection 1208390 - Legacy Pharmaceutical Packaging LLC - 2023-06-20](https://www.keypedia.com/records/fda_inspections/legacy-pharmaceutical-packaging-llc/8f48f781-195d-41df-95d3-68df44d49411) — classification: Voluntary Action Indicated (VAI), source: FDA, date: June 20, 2023 - FDA Inspection 1208390 - Legacy Pharmaceutical Packaging LLC - 2023-06-20 — classification: No Action Indicated (NAI), source: FDA, date: June 20, 2023 - [483 - Legacy Pharmaceutical Packaging LLC - 2022-04-27](https://www.keypedia.com/records/483/legacy-pharmaceutical-packaging-llc/75edfb0b-91b7-433b-8a62-206fbce3b285) — source: FDA, date: April 27, 2022 - [WARNING_LETTER - Legacy Pharmaceutical Packaging LLC - 2022-04-27](https://www.keypedia.com/records/warning_letter/legacy-pharmaceutical-packaging-llc/f5aa9520-e9a4-4050-99ff-c9f391ccc50d) — source: FDA, date: April 27, 2022 - [FDA Inspection 1169547 - Legacy Pharmaceutical Packaging LLC - 2022-04-27](https://www.keypedia.com/records/fda_inspections/legacy-pharmaceutical-packaging-llc/d2b934e2-ceca-4b26-8898-860533e7085a) — classification: Official Action Indicated (OAI), source: FDA, date: April 27, 2022 - [483 - Legacy Pharmaceutical Packaging LLC - 2020-01-16](https://www.keypedia.com/records/483/legacy-pharmaceutical-packaging-llc/6b58df57-672a-4311-a749-d866b42191ea) — source: FDA, date: January 16, 2020 - FDA Inspection 1115769 - Legacy Pharmaceutical Packaging LLC - 2020-01-16 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 16, 2020 - [EIR - Legacy Pharmaceutical Packaging LLC - 2019-01-25](https://www.keypedia.com/records/eir/legacy-pharmaceutical-packaging-llc/3d106d77-6536-4004-995c-813ba563faa7) — source: FDA, date: January 25, 2019 - [483 - Legacy Pharmaceutical Packaging LLC - 2019-01-25](https://www.keypedia.com/records/483/legacy-pharmaceutical-packaging-llc/02e153b7-4c6e-43b5-b9cf-afac93766658) — source: FDA, date: January 25, 2019 - FDA Inspection 1077095 - Legacy Pharmaceutical Packaging LLC - 2019-01-25 — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 25, 2019 - [FDA Inspection 1077095 - Legacy Pharmaceutical Packaging LLC - 2019-01-25](https://www.keypedia.com/records/fda_inspections/legacy-pharmaceutical-packaging-llc/d9ff9db3-9aee-439f-ac1f-ea1142c67004) — classification: Voluntary Action Indicated (VAI), source: FDA, date: January 25, 2019 - FDA Inspection 1013478 - Legacy Pharmaceutical Packaging LLC - 2017-05-26 — classification: No Action Indicated (NAI), source: FDA, date: May 26, 2017 - [FDA Inspection 1013478 - Legacy Pharmaceutical Packaging LLC - 2017-05-26](https://www.keypedia.com/records/fda_inspections/legacy-pharmaceutical-packaging-llc/cc64f6f4-6ec2-40a4-b171-ed13710fb483) — classification: Voluntary Action Indicated (VAI), source: FDA, date: May 26, 2017 ## Related Companies - [Aphena Pharma Solutions - Tennessee LLC](https://www.keypedia.com/companies/aphena-pharma-solutions-tennessee-llc/69de5617-e85d-4684-a5af-8c1ceb15bb7f) - [Sharp Packaging Services, LLC](https://www.keypedia.com/companies/sharp-packaging-services-llc/7b0af746-388f-48e7-8eda-3efbb4ccdab5) - [JAK Diversified II Inc.](https://www.keypedia.com/companies/jak-diversified-ii-inc/d09785e8-aaf2-4210-bcad-7454770e38b9) - [F. M. Howell & Company Inc.](https://www.keypedia.com/companies/f-m-howell-company-inc/66f677bb-732b-4bd2-a181-3048fe3416f2) - [Integrated Commercialization Solutions, Inc.](https://www.keypedia.com/companies/integrated-commercialization-solutions-inc/86c598b4-9604-4954-bfa0-90eb8ab14a0c) - [Custom Converting, Inc.](https://www.keypedia.com/companies/custom-converting-inc/81a6c34d-f33c-4b1c-a878-97ba6f7d1ccc) - [Brand-Nu Laboratories, Inc.](https://www.keypedia.com/companies/brand-nu-laboratories-inc/dcaff880-0e9b-4a20-b915-325f34a72c4f) - [United Exchange Corp.](https://www.keypedia.com/companies/united-exchange-corp/13fa0a23-b7b9-494a-8f81-a91a9fa8c52b) - [LE PAPILLON LTD.](https://www.keypedia.com/companies/le-papillon-ltd/9458aec0-27ba-4d80-856b-0888b8ad2d2b) - [Elizabeth Arden, Inc.](https://www.keypedia.com/companies/elizabeth-arden-inc/a4d59743-a137-447c-aeaf-0246e3b5e7d0) ## Related Officers - [investigator](https://www.keypedia.com/people/ana-paula-p-sandee/7c96feb2-cb1d-4808-a65c-eafba38c3b2d) - [Program Expert ](https://www.keypedia.com/people/michele-l-obert/7ac8155e-cc5a-4e89-a885-c68ce69adb4e) - [Edward E. Lockwood](https://www.keypedia.com/people/edward-e-lockwood/3260b39e-9211-489f-8247-0ec3353e57ca)